Daniel Barber Aquestive Therapeutics, Inc. (AQST) insider trading activity

Daniel Barber is President and CEO of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 1.02 Million shares of AQST, which is worth approximately $2.62 Million. The most recent transaction as insider was on Mar 09, 2025, when has been sold 53,998 shares (Common Stock) at a price of $2.65 per share, resulting in proceeds of $143,094. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.02M

20.09% 3M change

20.09% 12M change

Total Value Held $2.62 Million

Daniel Barber Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 09 2025	SELL Payment of exercise price or tax liability	$143,094 $2.65 p/Share	53,998 Reduced 5.05%	1,015,173 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$77,663 $2.65 p/Share	29,307 Reduced 2.67%	1,069,171 Common Stock
Mar 07 2025	BUY Grant, award, or other acquisition	-	272,000 Added 19.85%	1,098,478 Common Stock
Mar 09 2024	SELL Payment of exercise price or tax liability	$185,137 $4.88 p/Share	37,938 Reduced 4.3%	845,364 Common Stock
Mar 07 2024	BUY Grant, award, or other acquisition	-	242,600 Added 21.55%	883,302 Common Stock
Mar 09 2023	BUY Grant, award, or other acquisition	-	447,000 Added 41.1%	640,702 Common Stock
Jun 08 2022	BUY Open market or private purchase	$88,073 $0.96 p/Share	91,743 Added 32.14%	193,702 Common Stock

Daniel Barber

President and CEO

Warren, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Value

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST

Account